What’s Special About AI Risks and Remedies in Health Care?

The text explores AI in healthcare, highlighting its potential benefits, challenges, and the regulatory landscape. Attorneys, such as Sara Shanti and Erica Kraus, emphasize the need for regulatory guidance to navigate liability, licensing, and the role of AI as a diagnostic aid. Dr. Michael Levinson underscores AI's potential as a diagnostic tool but stresses the necessity for further research. The discussion delves into equity issues regarding bias in AI and the divergent perspectives on AI trust among consumers. ChatGPT and Bard acknowledge risks like over-reliance on AI and privacy concerns, suggesting transparency and regulation as solutions. The focus is on understanding and harnessing AI's potential in healthcare responsibly.